JAK2/JAK-2 Target & Gene Products-cDNA ORF clones/siRNA/antibody/protein

Explore JAK2/JAK-2 gene products and cross-species research data at TarMart platform. Discover comprehensive biological information, expression tools, and therapeutic insights for Homo sapiens (human), Cynomolgus monkeys, rodents (mouse/rat), canines, felines, bovines, and equines. Your premier destination for multi-species gene research solutions
Target sublocation: Transmembrane Protein.
This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]

Target ID GM-T08391
Target Name JAK2/JAK-2
Gene Group ldentifer
(Target Gene ID in Homo species)
3717
Gene ID 100051487 (Equus caballus), 101088959 (Felis catus), 16452 (Mus musculus), 24514 (Rattus norvegicus)
3717 (Homo sapiens), 484185 (Canis lupus familiaris), 525246 (Bos taurus), 694184 (Macaca mulatta)
Target Alternative Names Fd17,JAK-2,JAK2,JTK10,Jak2,Janus kinase 2 (JAK-2),Tyrosine-protein kinase JAK2
Uniprot Accession Q62120,Q62689,O60674
Protein Sub-location Transmembrane Protein
Category Therapeutics Target
Disease cancer
Disease from KEGG EGFR tyrosine kinase inhibitor resistance, Chemokine signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Growth hormone synthesis, secretion and action, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis B, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis
Gene Ensembl ENSECAG00000009119, ENSMUSG00000024789, ENSG00000096968, ENSCAFG00845015887, ENSBTAG00000012047, ENSMMUG00000014558
Target Classification Kinase, Tumor-associated antigen (TAA)


Pre-made viral vector of JAK2/JAK-2 cDNA Clones/ORF Plasmid

Cat No.Product NameNMIDGeneIDSpeciesTypeMarkerFusion TagPromoterDetail
pGMLPm003630Mouse Jak2/Fd17 Lentivirus plasmidXM_006526715.316452MouseLentivirus plasmidZsGreen3xflag (C-Terminal)CMVDetail
vGMLPm003630Mouse Jak2/Fd17 Lentivirus particleXM_006526715.316452MouseLentivirus particleZsGreen3xflag (C-Terminal)CMVDetail


JAK2/JAK-2 siRNA/miRNA/oligo for RNA interfence (RNAi)

Cat No.Product NameGeneIDSpeciesGradeDetail
pGMoligo3717Pre-made Human JAK2/JTK10 siRNA oligo Duplex3717HumanIn-vitro grade; in-vivo gradeDetail
pGMoligo24514Pre-made Rat Jak2 siRNA oligo Duplex24514RatIn-vitro grade; in-vivo gradeDetail
pGMoligo16452Pre-made Mouse Jak2/Fd17 siRNA oligo Duplex16452MouseIn-vitro grade; in-vivo gradeDetail
pGMoligo694184Pre-made Cynomolgus/Rhesus macaque JAK2 siRNA oligo Duplex694184Cynomolgus/Rhesus macaqueIn-vitro grade; in-vivo gradeDetail
pGMoligo101088959Pre-made Cat/Feline JAK2 siRNA oligo Duplex101088959Cat/FelineIn-vitro grade; in-vivo gradeDetail
pGMoligo484185Pre-made Dog/Canine JAK2 siRNA oligo Duplex484185Dog/CanineIn-vitro grade; in-vivo gradeDetail
pGMoligo525246Pre-made Bovines/Cattle JAK2 siRNA oligo Duplex525246Bovines/CattleIn-vitro grade; in-vivo gradeDetail
pGMoligo100051487Pre-made Equine/Horse JAK2 siRNA oligo Duplex100051487Equine/HorseIn-vitro grade; in-vivo gradeDetail


JAK2/JAK-2 antibody/GMab

Cat No.SpeciesAntibody NameFormatClassified by tagDetail
GM-Tg-hg-T08391-AbHumanAnti-Human JAK2/JAK-2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-rg-T08391-AbRatAnti-Rat JAK2/JAK-2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-mg-T08391-AbMouseAnti-Mouse JAK2/JAK-2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-cynog-T08391-AbCynomolgus/Rhesus macaqueAnti-Cynomolgus/Rhesus macaque JAK2/JAK-2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-felg-T08391-AbCat/FelineAnti-Cat/Feline JAK2/JAK-2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-cang-T08391-AbDog/CanineAnti-Dog/Canine JAK2/JAK-2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-bovg-T08391-AbBovines/CattleAnti-Bovines/Cattle JAK2/JAK-2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-equg-T08391-AbEquine/HorseAnti-Equine/Horse JAK2/JAK-2 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail


JAK2/JAK-2 VLP (virus-like particle)/protein

Cat No.SpeciesAntigen NameExpression PlatformDetail
GM-Tg-hg-T08391-AgHumanHuman JAK2/JAK-2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-rg-T08391-AgRatRat JAK2/JAK-2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-mg-T08391-AgMouseMouse JAK2/JAK-2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-cynog-T08391-AgCynomolgus/Rhesus macaqueCynomolgus/Rhesus macaque JAK2/JAK-2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-felg-T08391-AgCat/FelineCat/Feline JAK2/JAK-2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-cang-T08391-AgDog/CanineDog/Canine JAK2/JAK-2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-bovg-T08391-AgBovines/CattleBovines/Cattle JAK2/JAK-2 VLP (virus-like particle)HEK293Products Developing
GM-Tg-equg-T08391-AgEquine/HorseEquine/Horse JAK2/JAK-2 VLP (virus-like particle)HEK293Products Developing